Cannabics Pharmaceuticals Launches a Breast Cancer Treatment Research Program
- Thursday, June 3, 2021, 7:12
- PR Newswire
- Add a comment
TEL AVIV, Israel and BETHESDA, Md., June 3, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the launching of a new research program for the development of a Breast Cancer…
About the Author
admin has written 20655 stories on this site.